ישראל - עברית - Ministry of Health

taro international ltd - anastrozole 1 mg - tablets - anastrozole - treatment of advanced breast cancer in post menopausal women. efficay has not been demonstrated in estrogen receptor negative patients unless they had a previous positive clinical response to tamoxifen. adjuvant treatment of postmenopausal women with hormone receptor positive early invasive breast cancer. adjuvant treatment of early breast cancer in hormone receptor positive postmenopausal women who have received 2 to 3 years of adjuvant tamoxifen.

ישראל - עברית - Ministry of Health

inovamed ltd - letrozole 2.5 mg - film coated tablets - letrozole - for first-line treatment in postmenopausal women with hormone receptor positive or in whom hormone receptor status cannot be determined locally advanced or metastatic breast cancer. for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy.adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.

ישראל - עברית - Ministry of Health

inovamed ltd - exemestane 25 mg - film coated tablets - exemestane - exemestane inovamed is indicated for the treatment of advanced breast cancer (abc) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone. exemestane inovamed is also indicated for the treatment of postmenopausal women with abc whose disease has progressed following multiple hormonal therapies. exemestane inovamed is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breas cancer following 2-3 years of initial adjuvant tamoxifen therapy.

ישראל - עברית - Ministry of Health

taro international ltd, israel - propofol - תחליב להזרקה או אינפוזיה - propofol 10 mg/ml - propofol - propofol - propofol is a short acting intravenous anesthetic agent suitable for induction and maintenance of general anesthesia in adults. propofol may also be used for sedation of ventilated adult patients in intensive care and for anesthesia in pediatric surgery (for children of 3 years of age or older ) for surgical procedures which do not exceed 1 hour in duration. propofol may also be used for conscious sedation for surgical and diagnostic procedures.

ישראל - עברית - Ministry of Health

taro international ltd, israel - propofol - תחליב להזרקה או אינפוזיה - propofol 10 mg/ml - propofol - propofol - propofol is a short acting intravenous anesthetic agent suitable for induction and maintenance of general anesthesia in adults. propofol may also be used for sedation of ventilated adult patients in intensive care and for anesthesia in pediatric surgery (for children of 3 years of age or older ) for surgical procedures which do not exceed 1 hour in duration. propofol may also be used for conscious sedation for surgical and diagnostic procedures..

ישראל - עברית - Ministry of Health

taro international ltd, israel - propofol - תחליב להזרקה או אינפוזיה - propofol 20 mg/ml - propofol - propofol - propofol is a short-acting intravenous anesthetic agent suitable for induction and maintenance of general anesthesia in adults. propofol may also be used for sedation of ventilated adult patients receiving intensive care and for anesthesia in pediatric surgery (for children of three years of age or older) for surgical procedures which do not exceed one hour in duration. propofol may also be used for conscious sedation for surgical and diagnostic procedures.

ישראל - עברית - Ministry of Health

inovamed ltd - montelukast as sodium 5 mg - chewable tablets - montelukast - montelukast inovamed is indicated in pediatric patients 6 to 14 years of age for the prophylaxis and chronic treatment of asthma including prevention of daytime and nighttime symptoms the treatment of aspirin-sensitive asthmatic patients and the prevention of exercise-induced bronchoconstriction.montelukast inovamed is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. montelukast inovamed and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. montelukast inovamed is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and pediatric patients 6 to 14 years of age.

ישראל - עברית - Ministry of Health

inovamed ltd - montelukast as sodium 4 mg - chewable tablets - montelukast - montelukast inovamed is indicated in pediatric patients 2 to 5 years of age for the prophylaxis and chronic treatment of asthma including prevention of daytime and nighttime symptoms the treatment of aspirin-sensitive asthmatic patients and the prevention of exercise-induced bronchoconstriction. montelukast inovamed is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. montelukast inovamed and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. montelukast inovamed is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and pediatric patients 2 to 5 years of age.

ישראל - עברית - Ministry of Health

inovamed ltd - montelukast as sodium 10 mg - film coated tablets - montelukast - montelukast inovamed is indicated in adult and adolescents 15 years of age and older for the prophylaxis and chronic treatment of asthma including prevention of daytime and nighttime symptoms the treatment of aspirin-sensitive asthmatic patients and the prevention of exercise-induced bronchoconstriction.montelukast inovamed is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. montelukast inovamed and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. montelukast inovamed is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and adolescents 15 years of age and older.

ישראל - עברית - Ministry of Health

inovamed ltd - eplerenone - טבליות מצופות פילם - eplerenone 25 mg - eplerenone